Ceftazidime/avibactam alone or in combination with an aminoglycoside for treatment of carbapenem-resistant Enterobacterales infections: A retrospective cohort study

•Retrospective study of 303 CRE-infected patients treated with ceftazidime/avibactam.•Age, empiric aminoglycoside use, and ICU stay were associated with 30-day mortality.•Patients receiving an aminoglycoside were more likely to be in the ICU.•A subanalysis in only the patients who received an aminog...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of antimicrobial agents 2024-11, Vol.64 (5), p.107321-107321, Article 107321
Hauptverfasser:	Bulman, Zackery P., Cao, Lishan, Curry, Brooke N., Biagi, Mark, Vivo, Amanda, Suda, Katie J., Evans, Charlesnika T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Aminoglycoside Aminoglycosides - therapeutic use Anti-Bacterial Agents - therapeutic use Azabicyclo Compounds - therapeutic use Carbapenem-resistant Enterobacterales Carbapenem-Resistant Enterobacteriaceae - drug effects Ceftazidime - therapeutic use Ceftazidime/Avibactam Combinations Drug Combinations Drug Therapy, Combination Enterobacteriaceae Infections - drug therapy Enterobacteriaceae Infections - microbiology Enterobacteriaceae Infections - mortality Female Hospital Mortality Humans Male Middle Aged Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!